The book is essential for anyone interested in vaccine development, as it highlights the unique advantages of viral vector vaccines in triggering robust, long-lasting immunity and provides an in-depth exploration of the technology and advancements shaping the future of healthcare.
Viral vector vaccines have several unique advantages when compared to other vaccine platforms. These powerful vaccines are capable of triggering long-lasting cellular responses, such as cytotoxic T-lymphocytes, that eradicate virus-infected cells. Viral vector-based vaccines use a harmless virus to smuggle the instructions for making antigens from the disease-causing virus into cells, triggering protective immunity against them. In contrast to conventional antigen-containing vaccines, these vaccines use the body's natural defense system to produce antigens by using a modified virus to deliver genetic code for an antigen. Viral Vectors for Vaccine Delivery provides a comprehensive overview of viral vectors and their applications in vaccine delivery. Its chapters explore various aspects of viral vector technology, from the basic principles of viral vector construction to the latest advancements in gene editing and manufacturing.
Readers will find that the book
- Offers a deep dive into the world of viral vectors, covering their principles, applications, and potential impact on healthcare;
- Explores how viral vectors are revolutionizing vaccine development, providing a more effective and targeted approach to disease prevention;
- Discusses the potential of viral vectors to address emerging health challenges and contribute to a healthier world.
Audience
Research scholars, pharma-process engineers, research scientists, pharmacy students and professionals from the pharmaceutical and biopharmaceutical industry interested in drug discovery, chemical biology, computational chemistry, medicinal chemistry, and bioinformatics
Auflage
Sprache
Verlagsort
Dateigröße
ISBN-13
978-1-394-27155-9 (9781394271559)
Schweitzer Klassifikation
Vivek P. Chavda is an assistant professor in the Department of Pharmaceutics and Pharmaceutical Technology, L.M. College of Pharmacy, India with over eight years of experience in biologic research. He has over 250 peer-reviewed national and international publications, including 38 book chapters, seven edited books, ten book chapters, seven patents, and numerous newsletter articles to his credit. His research interests include the development of biologics processes and formulations, medical device development, nano-diagnostics, non-carrier formulations, long-acting parenteral formulations, and nano-vaccines.
Vasso Apostolopoulos, PhD, is the Vice-Chancellor's Distinguished Fellow and Director of the Immunology and Translational Research Group at Victoria University and the Immunology Program Director at the Australian Institute for Musculoskeletal Science. She has over 510 research publications and 22 patents to her credit and has received over 100 awards for her research work. Her research interests include vaccine and drug development for cancer, chronic, infectious, and autoimmune diseases.
